Fosun International LTD Abb Vie Inc. Transaction History

Fosun International LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $495,432 - $629,856	-3,600 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $168,336 - $187,536	1,600 Added 80.0%	3,600 $404,000
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $204,600 - $225,240	2,000 New	2,000 $214,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $6.05 Million - $7.27 Million	-96,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $6.31 Million - $8.06 Million	96,000 New	96,000 $6.72 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.